[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 2,590
Citations 0
From the JAMA Network
November 3, 2015

Diabetes Risk Assessment and Glycemic Control

Author Affiliations
  • 1Center for Clinical Management Research, Department of Internal Medicine, Ann Arbor Veterans Affairs Hospital, University of Michigan, Ann Arbor
JAMA. 2015;314(17):1861-1862. doi:10.1001/jama.2015.11518

Blood glucose control is considered the cornerstone of diabetes management. Clinical trials have shown that improving blood glucose can lower the risk of early microvascular complications, although no trials have had a long enough duration of follow-up to demonstrate significant reductions in end-stage outcomes such as visual loss, end-stage renal disease, or amputation. Nearly all diabetes clinical guidelines include recommendations to maintain tight glucose control, most commonly defined as a hemoglobin A1c (HbA1c) level of less than 7.0%, for the majority of patients with diabetes.

First Page Preview View Large
First page PDF preview
First page PDF preview